Second, the interaction between S100A10 and ANXA2 may involve other complex molecular mechanisms that require further exploration and the clinical application of S100A10 and ANXA2 in cardiovascular diseases requires evaluation through larger-scale clinical studies. Here, S100A10 is linked to cardiovascular disorder.